Sodium-glucose cotransporter-2 (SGLT2) inhibitors, including empagliflozin, canagliflozin, and dapagliflozin, represent another important class of repurposed agents with robust cardiovascular benefits
Treatment is not necessary
Executive summary of the KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease: an update based on rapidly emerging new evidence
"There are also important clinical concerns, such as whether FGF21 analogs can cause side effects like digestive issues and bone loss, which is especially risky since obesity already increases the chance of fractures," he cautioned
Its a tiny shot just under the skin, usually in the belly or thigh, and it takes only a few seconds
Stay consistent with strength training